Document is current
Any future updates will be listed below
-
Authors
Rovira, Paula
Sánchez-Mora, Cristina https://orcid.org/0000-0003-4211-1107
Pagerols, Mireia
Richarte, Vanesa
Corrales, Montserrat
Fadeuilhe, Christian
Vilar-Ribó, Laura https://orcid.org/0000-0001-8758-523X
Arribas, Lorena
Shireby, Gemma
Hannon, Eilis https://orcid.org/0000-0001-6840-072X
Mill, Jonathan https://orcid.org/0000-0003-1115-3224
Casas, Miquel
Ramos-Quiroga, Josep Antoni https://orcid.org/0000-0003-1622-0350
Soler Artigas, María https://orcid.org/0000-0002-3213-1107
Ribasés, Marta https://orcid.org/0000-0003-1039-1116
- License Information
-
More Information
Article History
Received: 13 November 2019
Revised: 5 May 2020
Accepted: 15 May 2020
First Online: 19 June 2020
Conflict of interest
: Paula Rovira, Dr. Sánchez-Mora, Dr. Pagerols, Laura Vilar-Ribó, Lorena Arribas, Gemma Shireby, Dr. Hannon, Prof. Mill, Dr. Soler Artigas and Dr. Ribasés reported no biomedical financial interests or potential conflicts of interest. Vanesa Richarte has served on the speakers for Eli Lilly, Rubio and Shire in the last 5 years. She has received travel awards from Eli Lilly and Co. and Shire for participating in psychiatric meetings. The ADHD Program has received unrestricted educational and research support from Eli Lilly and Co., Janssen-Cilag, Shire, Rovi, Psious and Laboratorios Rubió in the past 2 years. Montserrat Corrales received travel awards for taking part in psychiatric meetings from Shire. Christian Fadeuilhe received fees to give talks for Shire, Ferrer, Italfarmaco and Otsuka in the last 5 years. He also received travel awards (air tickets +hotel) for taking part in psychiatric meetings from Janssen-Cilag, Rubió, Shire, Lundbeck, Otsuka and Ferrer. Prof. Casas has received travel grants and research support from Eli Lilly and Co., Janssen-Cilag, Shire and Lundbeck and served as consultant for Eli Lilly and Co., Janssen-Cilag, Shire and Lundbeck. Prof. Ramos-Quiroga was on the speakers’ bureau and/or acted as consultant for Eli-Lilly, Janssen-Cilag, Novartis, Shire, Lundbeck, Almirall, Braingaze, Sincrolab, Medice, and Rubió in the last 5 years. He also received travel awards (air tickets + hotel) for taking part in psychiatric meetings from Janssen-Cilag, Rubió, Shire, Medice and Eli- Lilly. The Department of Psychiatry chaired by him received unrestricted educational and research support from the following companies in the last 5 years: Eli-Lilly, Lundbeck, Janssen- Cilag, Actelion, Shire, Ferrer, Oryzon, Roche, Psious, and Rubió.
